Viz.ai logoCompany profile

Viz.ai

Viz.ai has raised a total of $252 million in funding across multiple rounds, including a $40 million Conventional Debt round in March 2023, a $100 million Series D in April 2022, and a $71 million Series C in March 2021, reaching a $1.2 billion valuation. Founded in 2016 by Chris Mansi and David Golan, the San Francisco-based company develops AI-powered healthcare solutions that accelerate disease detection and care coordination. Backed by investors such as Insight Partners, Tiger Global Management, and Innovation Endeavors, Viz.ai is transforming emergency healthcare workflows worldwide.

Back to profiles

Quick facts

Total funding
$252 million
Valuation
$1.2 billion
Founded
2016

Notable investors

  • Tiger Global Management
  • Innovation Endeavors
  • Viz

Reach buyers like Viz.ai.

The 14-day trial ships every feature, no card required.